For the year ending 2025-12-31, INDP has $9,310,168 in assets. $8,507,628 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 8,507,628 | |||
| Prepaid expenses and other current assets | 802,540 | |||
| Total current assets | 9,310,168 | |||
| Total assets | 9,310,168 | |||
| Accounts payable and other current liabilities | 6,158,575 | |||
| Total current liabilities | 6,158,575 | |||
| Common stock 0.01 par value, 200,000,000 shares authorized as of december 31, 2025 and december 31, 2024 2,167,324 shares issued and outstanding as of december 31, 2025 and 428,799 shares issued and outstanding as of december 31, 2024 | 21,674 | |||
| Preferred stock 0.01 par value, 5,000,000 shares authorized as of december 31, 2025 and december 31, 2024 1,000,000 shares issued and outstanding as of december 31, 2025 and no shares issued and outstanding as of december 31, 2024 | 10,000 | |||
| Additional paid in capital | 84,408,018 | |||
| Accumulated deficit | -81,288,099 | |||
| Total stockholders equity | 3,151,593 | |||
| Total liabilities and stockholders equity | 9,310,168 | |||
Indaptus Therapeutics, Inc. (INDP)
Indaptus Therapeutics, Inc. (INDP)